Will Douglas Heaven is the senior editor for AI at MIT Technology Review. He’s based in London, England.
Segment
Read More
12:14
How AI Is Changing The Drug Development Pipeline
The first drugs designed with AI are now in clinical trials, raising new questions for the pharmaceutical industry.